Market Cap (In MYR)
511.63 Million
Revenue (In MYR)
3.4 Billion
Net Income (In MYR)
-80.16 Million
Avg. Volume
2.51 Million
- Currency
- MYR
- Country
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.295-0.47
- PE
- -
- EPS
- -
- Beta Value
- 1.409
- ISIN
- MYL7081OO002
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Industry
- CEO
- Mr. Zulkifli Bin Jafar
- Employee Count
- -
- Website
- https://www.pharmaniaga.com
- Ipo Date
- 2000-01-03
- Details
- Pharmaniaga Berhad, an investment holding company, operates as an integrated pharmaceutical company in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; supply, trading, and installation of medical and hospital equipment; and trading and wholesaling of consumer products. The company also manufactures and sells generic drugs; over-the-counter medicines; conducts research and development of pharmaceutical products; and manufactures, distributes, trades in, and sells food supplements. In addition, it distributes and trades in diagnostic products; and operates community pharmacies under the RoyalePharma brand name. The company was founded in 1994 and is based in Shah Alam, Malaysia. Pharmaniaga Berhad is a subsidiary of Boustead Holdings Berhad.
More Stocks
-
BFLY
-
000997
-
HPI
-
BY6
-
ASGLYAGC Inc.
ASGLY
-
SKWGSkywealth Group Inc.
SKWG
-
OTGLYCD Projekt S.A.
OTGLY
-
PE&OLES